Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06604078 · ClinicalTrials.gov registry record
Breast Cancer AI Imaging Study
A clinical trial, sponsored by University of Central Florida.
- Completed
- Registry status
- 199
- Enrollment target
NCT06604078 is a clinical trial that has completed, run by University of Central Florida. The registered enrollment target is 199 participants.
The verdict
NCT06604078 has completed, sponsored by University of Central Florida.
- COMPLETED
- Registry status
- 199 participants
- Enrollment target
Study Summary
This study aims to develop a social health platform called MammoChat (https://MammoChat.com) that allows patients to share their real-world patient data to a trusted network for development of clinical intelligence to improve patient outcomes. Therefore: 1. The investigator will establish a Discourse social network where patients can anonymously and securely share their breast imaging and interact with other patients. 2. The investigator will use standardized questionnaires to understand the impact of use of the social network on outcomes related to breast cancer screening such as anxiety. 3. The investigator will assemble a crowdsourced, de-identified radiographic repository for training, testing, and validating AI models aimed at earlier and more accurate disease detection for breast cancer.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 199 participants |
| Start Date | 2024-09-05 |
| Est. Completion | 2025-09-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06604078
The ClinicalTrials.gov registry entry for NCT06604078 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 199 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Central Florida, which has 91 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT06604078 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06604078 about?
NCT06604078 is a clinical study titled "Breast Cancer AI Imaging Study". This study aims to develop a social health platform called MammoChat (https://MammoChat.com) that allows patients to share their real-world patient data to a trusted network for development of clinical intelligence to improve patient outcomes. Therefore: 1. The investigator will establish a Discour...
What is the current status of trial NCT06604078?
This trial is currently completed. The enrollment target is 199 participants. The study started on 2024-09-05. Estimated completion is 2025-09-01.
Who is sponsoring clinical trial NCT06604078?
This trial is sponsored by University of Central Florida, which has 91 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.